Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
3F Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
3F Therapeutics

3F Therapeutics

Inactive

3F Therapeutics: Innovating heart surgery with advanced cardiovascular devices and valve systems.

HQ
Lake Forest, CA, US
Founded
1998
Overview
Compare
Fundraising
Employees
Website

3F Therapeutics specializes in developing and manufacturing advanced cardiovascular devices for heart surgeries. The company focuses on innovative technologies for aortic heart valve replacement, offering products such as the Enable aortic heart valve, Entrata aortic valve system, and Endurance valve system. These devices aim to improve surgical outcomes by reducing cross-clamp and cardiopulmonary bypass time.

The company's products are designed to address the needs of patients with congestive heart failure and other cardiovascular conditions. 3F Therapeutics' technologies contribute to advancing minimally invasive cardiac procedures, potentially improving patient recovery and overall surgical efficiency in the field of cardiovascular medicine.

3F Therapeutics - Similar Companies

Arbor Surgical Technologies logo

Arbor Surgical Technologies

Thubrikar Aortic Valve logo

Thubrikar Aortic Valve

tavi.us

TriFlo Cardiovascular logo

TriFlo Cardiovascular

triflocv.com

TransCardiac Therapeutics logo

TransCardiac Therapeutics

Viacor logo

Viacor

Colibri Heart Valve logo

Colibri Heart Valve

colibrihv.com

CardioFocus logo

CardioFocus

cardiofocus.com

Ancora Heart logo

Ancora Heart

ancoraheart.com

InterValve logo

InterValve

Tau-Pnu Medical logo

Tau-Pnu Medical

Emboline logo

Emboline

Edwards Lifesciences logo

Edwards Lifesciences

edwards.com

Transverse Medical logo

Transverse Medical

Cardiac Dimensions logo

Cardiac Dimensions

Phoenix Cardiac logo

Phoenix Cardiac

3F Therapeutics - Quick Facts

Who are 3F Therapeutics' competitors?

Companies similar to 3F Therapeutics include Arbor Surgical Technologies, Thubrikar Aortic Valve, TriFlo Cardiovascular and TransCardiac Therapeutics.

When was 3F Therapeutics founded?

3F Therapeutics was founded in 1998.

Where is 3F Therapeutics' headquarters located?

3F Therapeutics' headquarters is located in Lake Forest, CA, US.

When was 3F Therapeutics' last funding round?

3F Therapeutics' most recent funding round was for $6M (USD) in April 2005.

How much has 3F Therapeutics raised to-date?

As of Apr 25, 2005, 3F Therapeutics has raised a total of $20.2M (USD).

3F Therapeutics - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Transactional
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified